The Cigna Group
CI · NYSE
CI · NYSE
The Cigna Group is a healthcare company operating through Cigna Healthcare and Evernorth. Cigna Healthcare provides health coverage, while Evernorth supplies health services, including pharmacy-related capabilities; the evidence identifies both businesses as contributors to second-quarter performance but does not provide their revenue proportions. The company serves healthcare customers through this diversified portfolio, although the supplied material does not break out customer types. Cigna generated $274.9 billion of revenue and $6.0 billion of net income in fiscal 2025, compared with $247.1 billion and $3.4 billion, respectively, in fiscal 2024.
The Cigna Group fell $27.01, or 8.97%, from $301.06 to $274.05 over the reported week. Shares declined for four straight sessions through July 31, slipping to $279.05, before a modest rebound to $282.06 on August 3 and a heavier-volume drop to $274.05 on August 4. The main company-specific event was second-quarter reporting: Cigna beat earnings and revenue estimates, Cigna Healthcare supported growth, and management raised its full-year 2026 adjusted earnings outlook again. Those positives were accompanied by higher pharmacy costs, which may have limited the response. The supplied evidence does not identify a separate market-wide catalyst or explain why the stock sold off despite the improved outlook.
